Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit A-site decoding region of 16S rRNA is a fundamental component of the bacterial translation apparatus, specifically located within Helix 44 (Vicens & Westhof, 2001, Chem & Bio). Its primary biological role is to ensure the accuracy of protein synthesis by facilitating the decoding of mRNA codons through the selection of cognate aminoacyl-tRNAs (PubMed: 11551172). During this process, the conserved adenine residues A1492 and A1493 undergo a conformational shift to stabilize correct codon-anticodon interactions. This region serves as the principal therapeutic target for aminoglycoside antibiotics, which bind to the A-site and lock it into an active state (StatPearls, 2023). This binding causes the ribosome to misread mRNA, leading to the production of aberrant, misfolded proteins that compromise the bacterial cell membrane and trigger cell death (DrugBank Online). Furthermore, the interaction inhibits the translocation of the ribosome along the mRNA strand, effectively halting protein production. Because of the structural similarity between the bacterial 16S rRNA and human mitochondrial 12S rRNA, drugs targeting this site can sometimes cause adverse effects such as hearing loss and kidney damage. Resistance to drugs targeting this site often arises through enzymatic modification of the rRNA or the drugs themselves, posing a significant challenge in clinical settings (NIH: PMC3516441).
Aminoglycosides bind to the internal loop of the 16S rRNA A-site, inducing a conformational change in residues A1492 and A1493 that mimics correct codon-anticodon pairing, leading to mRNA misreading and inhibition of translocation (PubMed: 11551172).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 16S ribosomal RNA aminoacyl-tRNA site (A-site) (16S rRNA A-site).